Gina-eva P. Gortz

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

TNFα drives disease-specific chemokine networks and orbital tissue remodeling in a preclinical model of thyroid eye disease.

TNFα drives disease-specific chemokine networks and orbital tissue remodeling in a preclinical model of thyroid eye disease.

Journal: European thyroid journal

Published: December 18, 2025

TNFα Drives Disease-Specific Chemokine Networks and Orbital Tissue Remodeling in a Preclinical Model of Thyroid Eye Disease.

TNFα Drives Disease-Specific Chemokine Networks and Orbital Tissue Remodeling in a Preclinical Model of Thyroid Eye Disease.

Journal: European thyroid journal

Published: December 18, 2025

Maraviroc attenuates orbital remodeling, inflammation, and lipid dysregulation in a murine model of thyroid eye disease associated with Graves' disease.

Maraviroc attenuates orbital remodeling, inflammation, and lipid dysregulation in a murine model of thyroid eye disease associated with Graves' disease.

Journal: Frontiers in endocrinology

Published: October 01, 2025

Current Therapeutic Approaches for Graves' Orbitopathy - are Targeted Therapies the Future?

Current Therapeutic Approaches for Graves' Orbitopathy - are Targeted Therapies the Future?

Journal: Klinische Monatsblatter fur Augenheilkunde

Published: October 06, 2023

Cigarette smoke causes a bioenergetic crisis in RPE cells involving the downregulation of HIF-1α under normoxia.

Cigarette smoke causes a bioenergetic crisis in RPE cells involving the downregulation of HIF-1α under normoxia.

Journal: Cell death discovery

Published: August 16, 2023

Potential involvement of the bone marrow in experimental Graves' disease and thyroid eye disease.

Potential involvement of the bone marrow in experimental Graves' disease and thyroid eye disease.

Journal: Frontiers in endocrinology

Published: July 17, 2023

Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease.

Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease.

Journal: Frontiers in endocrinology

Published: April 24, 2023

Sphingolipids in thyroid eye disease.

Sphingolipids in thyroid eye disease.

Journal: Frontiers in endocrinology

Published: February 21, 2023

Macrophage-Orbital Fibroblast Interaction and Hypoxia Promote Inflammation and Adipogenesis in Graves' Orbitopathy.

Macrophage-Orbital Fibroblast Interaction and Hypoxia Promote Inflammation and Adipogenesis in Graves' Orbitopathy.

Journal: Endocrinology

Published: August 23, 2022

An Early Wave of Macrophage Infiltration Intertwined with Antigen-Specific Proinflammatory T Cells and Browning of Adipose Tissue Characterizes the Onset of Orbital Inflammation in a Mouse Model of Graves' Orbitopathy.

An Early Wave of Macrophage Infiltration Intertwined with Antigen-Specific Proinflammatory T Cells and Browning of Adipose Tissue Characterizes the Onset of Orbital Inflammation in a Mouse Model of Graves' Orbitopathy.

Journal: Thyroid : official journal of the American Thyroid Association

Published: November 15, 2021

Lessons from mouse models of Graves' disease.

Lessons from mouse models of Graves' disease.

Journal: Endocrine

Published: November 26, 2019

Graves' orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model.

Graves' orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model.

Journal: Scientific reports

Published: May 29, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026